Two antibodies with novel mechanisms of actions
Focused on Suppressing Immune Cell Activation
Target two key pathogenic cells shown to be highly relevant in Inflammation & Immunology
Significant Commercial Opportunity
Potential in Multiple Inflammation & Immunology Indications: Atopic Dermatitis, Chronic Urticaria and Eosinophilic Gastrointestinal Disorders
An investigational monoclonal antibody that potently depletes eosinophils and inhibits mast cells
An investigational monoclonal antibody that selectively and potently inhibits mast cells, including KIT mediated signaling